BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.62
+0.14 (1.65%)
At close: Mar 9, 2026, 4:00 PM EDT
8.59
-0.03 (-0.35%)
After-hours: Mar 9, 2026, 7:17 PM EDT
BioCryst Pharmaceuticals Revenue by Segment
History
| Date | Other | Orladeyo |
|---|---|---|
| Dec 31, 2025 | 273.00M | 601.84M |
| Sep 30, 2025 | 25.47M | 574.34M |
| Jun 30, 2025 | 25.92M | 531.59M |
| Mar 31, 2025 | 20.45M | 483.04M |
| Dec 31, 2024 | 13.05M | 437.66M |
| Sep 30, 2024 | 8.22M | 404.36M |
| Jun 30, 2024 | 8.51M | 373.72M |
| Mar 31, 2024 | 8.95M | 346.44M |
| Dec 31, 2023 | 5.42M | 325.99M |
| Sep 30, 2023 | 11.72M | 305.84M |
| Jun 30, 2023 | 20.51M | 286.13M |
| Mar 31, 2023 | 19.34M | 270.34M |
| Dec 31, 2022 | 19.19M | 251.63M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.